Transpek Industry Ltd
Incorporated in 1965, Transpek Industry Limited is into the manufacturing and export of a range of chemicals servicing the requirements of customers from a diverse range of industries including Textiles, Pharmaceuticals, Agrochemicals, Advanced Polymers, etc. [1]
- Market Cap ₹ 1,030 Cr.
- Current Price ₹ 1,844
- High / Low ₹ 2,185 / 1,510
- Stock P/E 32.2
- Book Value ₹ 1,206
- Dividend Yield 0.76 %
- ROCE 9.47 %
- ROE 6.12 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has been maintaining a healthy dividend payout of 19.3%
Cons
- Company has a low return on equity of 12.1% over last 3 years.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
242 | 269 | 290 | 284 | 317 | 361 | 595 | 566 | 339 | 599 | 827 | 580 | 569 | |
216 | 242 | 251 | 236 | 263 | 314 | 478 | 447 | 292 | 499 | 676 | 497 | 494 | |
Operating Profit | 26 | 27 | 38 | 48 | 53 | 47 | 117 | 118 | 47 | 100 | 151 | 82 | 76 |
OPM % | 11% | 10% | 13% | 17% | 17% | 13% | 20% | 21% | 14% | 17% | 18% | 14% | 13% |
4 | 8 | 11 | 2 | 7 | 10 | 18 | 17 | 17 | 24 | 14 | 25 | 24 | |
Interest | 14 | 14 | 13 | 11 | 9 | 12 | 19 | 16 | 10 | 11 | 19 | 14 | 13 |
Depreciation | 8 | 9 | 9 | 8 | 9 | 10 | 14 | 26 | 29 | 30 | 33 | 38 | 41 |
Profit before tax | 8 | 12 | 27 | 32 | 42 | 35 | 101 | 94 | 26 | 84 | 113 | 56 | 46 |
Tax % | 9% | 38% | 18% | 33% | 29% | 25% | 35% | 22% | 9% | 22% | 26% | 31% | |
7 | 8 | 22 | 21 | 30 | 26 | 66 | 73 | 23 | 65 | 83 | 39 | 32 | |
EPS in Rs | 12.52 | 12.82 | 37.41 | 36.24 | 53.67 | 47.26 | 117.70 | 130.59 | 41.73 | 117.09 | 149.46 | 69.03 | 57.29 |
Dividend Payout % | 24% | 19% | 13% | 21% | 17% | 19% | 17% | 10% | 18% | 19% | 18% | 20% |
Compounded Sales Growth | |
---|---|
10 Years: | 8% |
5 Years: | -1% |
3 Years: | 20% |
TTM: | -27% |
Compounded Profit Growth | |
---|---|
10 Years: | 18% |
5 Years: | -10% |
3 Years: | 20% |
TTM: | -61% |
Stock Price CAGR | |
---|---|
10 Years: | 25% |
5 Years: | 9% |
3 Years: | -4% |
1 Year: | -2% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 13% |
3 Years: | 12% |
Last Year: | 6% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Reserves | 45 | 50 | 69 | 85 | 200 | 241 | 306 | 333 | 374 | 479 | 581 | 668 |
104 | 101 | 77 | 64 | 88 | 203 | 144 | 116 | 111 | 137 | 145 | 70 | |
65 | 87 | 77 | 55 | 93 | 116 | 143 | 134 | 109 | 143 | 155 | 222 | |
Total Liabilities | 219 | 244 | 229 | 209 | 386 | 566 | 599 | 589 | 599 | 764 | 887 | 966 |
113 | 106 | 92 | 94 | 117 | 179 | 236 | 287 | 287 | 295 | 365 | 397 | |
CWIP | 2 | 5 | 5 | 10 | 13 | 56 | 33 | 19 | 14 | 16 | 24 | 6 |
Investments | 4 | 4 | 5 | 5 | 131 | 144 | 149 | 118 | 142 | 196 | 238 | 321 |
101 | 129 | 126 | 100 | 125 | 188 | 180 | 166 | 156 | 258 | 260 | 242 | |
Total Assets | 219 | 244 | 229 | 209 | 386 | 566 | 599 | 589 | 599 | 764 | 887 | 966 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
20 | 26 | 19 | 44 | 47 | 7 | 128 | 111 | 35 | 47 | 111 | 98 | |
-5 | -9 | 14 | -16 | -31 | -103 | -45 | -33 | -17 | -70 | -13 | -32 | |
-14 | -17 | -33 | -27 | -17 | 96 | -83 | -77 | -3 | 9 | -94 | -64 | |
Net Cash Flow | 1 | -0 | -0 | 1 | -1 | 0 | -0 | 0 | 15 | -14 | 4 | 3 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 83 | 100 | 103 | 59 | 78 | 94 | 57 | 58 | 82 | 60 | 52 | 58 |
Inventory Days | 90 | 89 | 68 | 111 | 91 | 87 | 68 | 70 | 82 | 77 | 54 | 82 |
Days Payable | 123 | 146 | 114 | 60 | 83 | 103 | 72 | 73 | 81 | 65 | 45 | 58 |
Cash Conversion Cycle | 50 | 43 | 57 | 110 | 85 | 78 | 54 | 54 | 83 | 72 | 61 | 81 |
Working Capital Days | 25 | 21 | 64 | 61 | 62 | 88 | 42 | 60 | 91 | 75 | 60 | 76 |
ROCE % | 14% | 17% | 22% | 28% | 23% | 13% | 27% | 24% | 7% | 18% | 20% | 9% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Investor Presentation 23 Aug
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 13 Aug
- Book Closure Intimation Pursuant To Provisions Of Regulation 42 Of SEBI LODR Regulations And Section 91 Of Companies Act, 2013. 12 Aug
- Announcement under Regulation 30 (LODR)-Change in Directorate 8 Aug
- Unaudited Financial Results For The Quarter Ended 30.06.2024 8 Aug
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Concalls
-
Aug 2024TranscriptNotesPPT
-
Jun 2024Transcript PPT
-
Mar 2024TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
Jun 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Sep 2022Transcript PPT
-
Jun 2022TranscriptNotesPPT
-
Jun 2022TranscriptNotesPPT
-
Mar 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Dec 2021TranscriptNotesPPT
-
Aug 2021Transcript PPT
-
Jun 2021TranscriptNotesPPT
-
Feb 2021Transcript PPT
-
Nov 2020TranscriptNotesPPT
-
Sep 2020Transcript PPT
Product Portfolio
Co. manufactures chlorinated products used as intermediates and specialty chemicals for applications in Specialty Chemicals, Surfactants, Agrochemicals, Dyes, Polymers, and Pharma. [1]